Literature DB >> 24977986

Postmortem ultrastructural analysis of a cornea transplanted with Descemet membrane endothelial keratoplasty.

Eitan Livny1, Jack S Parker, Mariëlle van der Kaaij, Elize D Haasdijk, Jacqueline van der Wees, Marieke Bruinsma, Gerrit R J Melles.   

Abstract

PURPOSE: The aim of this study was to describe the ultrastructure of the host-donor interface in the eye of a recently deceased patient, who had undergone Descemet membrane endothelial keratoplasty.
METHODS: The eye was enucleated postmortem, and after standard decontamination, the corneoscleral button was excised, cut into 4 quadrants, and processed for light and transmission electron microscopy evaluation.
RESULTS: Transmission electron microscopy revealed close attachment of the donor's Descemet membrane to the host's stroma and projection of stromal collagen fibers into the interfacial matrix, resembling a normal "virgin" corneal architecture.
CONCLUSIONS: Ultrastructurally, an attached Descemet membrane endothelial keratoplasty graft closely resembles that of an unoperated, healthy eye with no appreciable adventitious or missing structures.

Entities:  

Mesh:

Year:  2014        PMID: 24977986     DOI: 10.1097/ICO.0000000000000156

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  Comparative analysis of biomechanical parameters of the corneas following Descemet membrane endothelial keratoplasty and contralateral healthy corneas.

Authors:  Natalya F Shilova; Yoav Nahum; Avital Adler; Irit Bahar; Boris E Malyugin; Natalia S Anisimova; Eitan Livny
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-11       Impact factor: 3.117

2.  Comparison of Descemet stripping under continuous air flow, manual air injection and balanced salt solution for DMEK: a pilot study.

Authors:  I E Gabbay; I Bahar; Y Nahum; E Livny
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-29       Impact factor: 3.117

3.  Descemet membrane endothelial keratoplasty: analysis of clinical outcomes of patients with 8-10 years follow-up.

Authors:  Julia M Weller; Friedrich E Kruse; Theofilos Tourtas
Journal:  Int Ophthalmol       Date:  2022-01-08       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.